Cargando…

Parathyroid Hormone-Related Protein (PTHrP) Accelerates Soluble RANKL Signals for Downregulation of Osteogenesis of Bone Mesenchymal Stem Cells

A recent study reported the expression of receptor activator of nuclear factor-κB (RANK) in mesenchymal stem cells (MSCs) surface that negatively regulates osteogenesis of MSCs. Empirical evidence from the previous study confirmed the role of parathyroid hormone-related protein (PTHrP) in osteoblast...

Descripción completa

Detalles Bibliográficos
Autores principales: Elango, Jeevithan, Rahman, Saeed Ur, Henrotin, Yves, de Val, José Eduardo Maté Sánchez, Bao, Bin, Wang, Shujun, Li, Bailin, Wu, Wenhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616973/
https://www.ncbi.nlm.nih.gov/pubmed/31212822
http://dx.doi.org/10.3390/jcm8060836
_version_ 1783433585045274624
author Elango, Jeevithan
Rahman, Saeed Ur
Henrotin, Yves
de Val, José Eduardo Maté Sánchez
Bao, Bin
Wang, Shujun
Li, Bailin
Wu, Wenhui
author_facet Elango, Jeevithan
Rahman, Saeed Ur
Henrotin, Yves
de Val, José Eduardo Maté Sánchez
Bao, Bin
Wang, Shujun
Li, Bailin
Wu, Wenhui
author_sort Elango, Jeevithan
collection PubMed
description A recent study reported the expression of receptor activator of nuclear factor-κB (RANK) in mesenchymal stem cells (MSCs) surface that negatively regulates osteogenesis of MSCs. Empirical evidence from the previous study confirmed the role of parathyroid hormone-related protein (PTHrP) in osteoblastogenesis. However, it is necessary to understand the paracrine role of PTHrP and RANKL for osteogenesis in order to explore the hidden secrets in bone biology. Considering the above concept, paracrine cues of soluble-receptor activator of nuclear factor-κB ligand (sRANKL) and PTHrP in osteogenic differentiation of MSCs were investigated. Our results confirmed that sRANKL increased the expression of surface-RANK in MSCs at the earlier stage of osteogenesis, which was downregulated later in differentiated MSCs. In contrast, RANKL expression was low at the earlier stage of MSCs proliferation and high at the differentiation stage of MSCs, which may play a fundamental role in osteoclast formation. sRANKL downregulated osteogenesis of MSCs by decreasing progressive ankylosis (ANK) protein expression while PTHrP upregulated the osteogenic exploitive effect of sRANKL. Interestingly, when they were co-cultured with MSCs, T-lymphocytes expressed high membrane-RANKL levels that contribute to osteogenesis inhibition during MSC differentiation. Thus, our results disclose that sRANKL treatment downregulates osteogenesis of MSCs by increasing RANK expression at the earlier stage of differentiation and by inhibiting ANK. Further, we demonstrated that PTHrP accelerated the downregulating osteogenic effect of sRANKL.
format Online
Article
Text
id pubmed-6616973
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66169732019-07-18 Parathyroid Hormone-Related Protein (PTHrP) Accelerates Soluble RANKL Signals for Downregulation of Osteogenesis of Bone Mesenchymal Stem Cells Elango, Jeevithan Rahman, Saeed Ur Henrotin, Yves de Val, José Eduardo Maté Sánchez Bao, Bin Wang, Shujun Li, Bailin Wu, Wenhui J Clin Med Article A recent study reported the expression of receptor activator of nuclear factor-κB (RANK) in mesenchymal stem cells (MSCs) surface that negatively regulates osteogenesis of MSCs. Empirical evidence from the previous study confirmed the role of parathyroid hormone-related protein (PTHrP) in osteoblastogenesis. However, it is necessary to understand the paracrine role of PTHrP and RANKL for osteogenesis in order to explore the hidden secrets in bone biology. Considering the above concept, paracrine cues of soluble-receptor activator of nuclear factor-κB ligand (sRANKL) and PTHrP in osteogenic differentiation of MSCs were investigated. Our results confirmed that sRANKL increased the expression of surface-RANK in MSCs at the earlier stage of osteogenesis, which was downregulated later in differentiated MSCs. In contrast, RANKL expression was low at the earlier stage of MSCs proliferation and high at the differentiation stage of MSCs, which may play a fundamental role in osteoclast formation. sRANKL downregulated osteogenesis of MSCs by decreasing progressive ankylosis (ANK) protein expression while PTHrP upregulated the osteogenic exploitive effect of sRANKL. Interestingly, when they were co-cultured with MSCs, T-lymphocytes expressed high membrane-RANKL levels that contribute to osteogenesis inhibition during MSC differentiation. Thus, our results disclose that sRANKL treatment downregulates osteogenesis of MSCs by increasing RANK expression at the earlier stage of differentiation and by inhibiting ANK. Further, we demonstrated that PTHrP accelerated the downregulating osteogenic effect of sRANKL. MDPI 2019-06-12 /pmc/articles/PMC6616973/ /pubmed/31212822 http://dx.doi.org/10.3390/jcm8060836 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Elango, Jeevithan
Rahman, Saeed Ur
Henrotin, Yves
de Val, José Eduardo Maté Sánchez
Bao, Bin
Wang, Shujun
Li, Bailin
Wu, Wenhui
Parathyroid Hormone-Related Protein (PTHrP) Accelerates Soluble RANKL Signals for Downregulation of Osteogenesis of Bone Mesenchymal Stem Cells
title Parathyroid Hormone-Related Protein (PTHrP) Accelerates Soluble RANKL Signals for Downregulation of Osteogenesis of Bone Mesenchymal Stem Cells
title_full Parathyroid Hormone-Related Protein (PTHrP) Accelerates Soluble RANKL Signals for Downregulation of Osteogenesis of Bone Mesenchymal Stem Cells
title_fullStr Parathyroid Hormone-Related Protein (PTHrP) Accelerates Soluble RANKL Signals for Downregulation of Osteogenesis of Bone Mesenchymal Stem Cells
title_full_unstemmed Parathyroid Hormone-Related Protein (PTHrP) Accelerates Soluble RANKL Signals for Downregulation of Osteogenesis of Bone Mesenchymal Stem Cells
title_short Parathyroid Hormone-Related Protein (PTHrP) Accelerates Soluble RANKL Signals for Downregulation of Osteogenesis of Bone Mesenchymal Stem Cells
title_sort parathyroid hormone-related protein (pthrp) accelerates soluble rankl signals for downregulation of osteogenesis of bone mesenchymal stem cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616973/
https://www.ncbi.nlm.nih.gov/pubmed/31212822
http://dx.doi.org/10.3390/jcm8060836
work_keys_str_mv AT elangojeevithan parathyroidhormonerelatedproteinpthrpacceleratessolubleranklsignalsfordownregulationofosteogenesisofbonemesenchymalstemcells
AT rahmansaeedur parathyroidhormonerelatedproteinpthrpacceleratessolubleranklsignalsfordownregulationofosteogenesisofbonemesenchymalstemcells
AT henrotinyves parathyroidhormonerelatedproteinpthrpacceleratessolubleranklsignalsfordownregulationofosteogenesisofbonemesenchymalstemcells
AT devaljoseeduardomatesanchez parathyroidhormonerelatedproteinpthrpacceleratessolubleranklsignalsfordownregulationofosteogenesisofbonemesenchymalstemcells
AT baobin parathyroidhormonerelatedproteinpthrpacceleratessolubleranklsignalsfordownregulationofosteogenesisofbonemesenchymalstemcells
AT wangshujun parathyroidhormonerelatedproteinpthrpacceleratessolubleranklsignalsfordownregulationofosteogenesisofbonemesenchymalstemcells
AT libailin parathyroidhormonerelatedproteinpthrpacceleratessolubleranklsignalsfordownregulationofosteogenesisofbonemesenchymalstemcells
AT wuwenhui parathyroidhormonerelatedproteinpthrpacceleratessolubleranklsignalsfordownregulationofosteogenesisofbonemesenchymalstemcells